Short Sunpharma on technical analysis till 1680

9 maj

Siunpharma looks week in daily chart and seems it can fall 1680 zone as per price support on that area where bulls vcan activate and bears will close their position.

📈 Technical Indicators
Moving Averages: Strong Sell

Technical Indicators: Strong Sell

RSI (14): 31.939 (Approaching oversold territory)

MACD (12,26): -13.57 (Bearish)

ADX (14): 30.04 (Indicates trend strength)

Williams %R: -97.69 (Oversold)

🔍 Demand & Resistance Zones
Demand Zone: ₹1,840–₹1,850

Sellers' Liquidity Zone: ₹1,920

Major Resistance: ₹1,960 (All-time high on Sep 30, 2024)

📌 Trade Setup
Entry: Consider long positions near ₹1,850 or upon breakout above ₹1,860

Targets:

Target 1: ₹1,920

Target 2: ₹1,960

Stop-Loss: Below ₹1,820

Risk-Reward Ratio: Minimum 1:2

🧠 Fundamental Insights
Analyst Consensus: Buy

12-Month Price Target: Average ₹2,051.84 (Upside of ~14.98%)

EPS Growth Forecast: 12.3% per annum

Revenue Growth Forecast: 9.8% per annum

Return on Equity Forecast: 16.9% over 3 years

🧬 Recent Developments
Acquisition: Acquired Checkpoint Therapeutics for $355 million in March 2025, enhancing oncology portfolio

Earnings Beat: Q3 FY25 EPS of ₹13.40 vs. estimate of ₹11.98; Revenue of ₹136.75B vs. estimate of ₹133.98B

12 maj

Transakcja zamknięta: osiągnięto wyznaczony cel

Sunpharma low was 1626 target achieved and its 100 point fall. amazing trade.

12 maj

Uwaga